Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
PBM Concerns Induce Surprising Bipartisanship

PBM Concerns Induce Surprising Bipartisanship

May 31, 2023 | Commentary

Recent congressional focus on the business practices of pharmacy benefit managers (PBMs) has been intense. Six committees have held 11 hearings related to PBMs in the first 20 weeks of the 118th Congress, and legislation is advancing in both chambers.

  • Analysis (54)
  • Books (3)
  • Commentary (15)
  • Events (22)
  • Interviews (61)
  • News (55)
  • Op-Eds (102)
  • Press Releases (4)
  • Testimony (21)
  • Brill discusses tax code and budget challenges
    ‘Facing the Future’: Alex Brill discusses tax code and budget challengesApril 9, 2026
  • Building an Achievable Fiscal Policy
    2026 Portman Center Symposium: Building an Achievable Fiscal PolicyApril 8, 2026
  • Reduced Charitable Giving
    Senator Booker’s Costly Standard Deduction Proposal Would Reduce Charitable GivingApril 7, 2026
  • FDA Continues to Expedite Biosimilar Development
    FDA Continues to Expedite Biosimilar DevelopmentMarch 18, 2026
  • Government’s Drug Negotiation Program
    Diminishing Returns from the Government’s Drug Negotiation ProgramJanuary 29, 2026
  • ACA Tax Credit Extension Matter
    Would Senate Passage of an ACA Tax Credit Extension Matter?January 14, 2026
  • PBMs Pass Through Rebates
    MGA Brief Examines State and Federal PBM MandatesDecember 1, 2025
  • FDA Moves to Facilitate Biosimilar Development
    FDA Moves to Facilitate Biosimilar DevelopmentOctober 30, 2025
  • How Pharmaceutical Tariffs Will Affect US Health Care Costs
    How Pharmaceutical Tariffs Will Affect US Health Care CostsSeptember 26, 2025
  • Quantifying the economic impact of healthcare distributors
    MGA Releases New Report Quantifying the Economic Impact of Healthcare DistributorsSeptember 17, 2025
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact